4â³-Sulfation Is the Major Metabolic Pathway of Epigallocatechin-3-gallate in Humans: Characterization of Metabolites, Enzymatic Analysis, and Pharmacokinetic Profiling.
J Agric Food Chem
; 70(27): 8264-8273, 2022 Jul 13.
Article
em En
| MEDLINE
| ID: mdl-35786898
ABSTRACT
Epigallocatechin-3-gallate (EGCG), a major green tea polyphenol, has beneficial effects on human health. This study aimed to elucidate the detailed EGCG sulfation process to better understand its phase II metabolism, a process required to maximize its health benefits. Results show that kinetic activity of sulfation in the human liver and intestinal cytosol is 2-fold and 60- to 300-fold higher than that of methylation and glucuronidation, respectively, suggesting sulfation as the key metabolic pathway. Moreover, SULT1A1 and SULT1A3 are responsible for sulfation in the liver and intestine, respectively. Additionally, our human ingestion study revealed that the concentration of EGCG-4â³-sulfate in human plasma (Cmax 177.9 nmol·L-1, AUC 715.2 nmol·h·L-1) is equivalent to free EGCG (Cmax 233.5 nmol·L-1, AUC 664.1 nmol·h·L-1), suggesting that EGCG-4â³-sulfate is the key metabolite. These findings indicate that sulfation is a crucial factor for improving EGCG bioavailability, while also advancing the understanding of the bioactivity and toxicity of EGCG.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Catequina
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article